Your browser doesn't support javascript.
loading
The genomic epidemiology of multi-drug resistant invasive non-typhoidal Salmonella in selected sub-Saharan African countries.
Park, Se Eun; Pham, Duy Thanh; Pak, Gi Deok; Panzner, Ursula; Maria Cruz Espinoza, Ligia; von Kalckreuth, Vera; Im, Justin; Mogeni, Ondari D; Schütt-Gerowitt, Heidi; Crump, John A; Breiman, Robert F; Adu-Sarkodie, Yaw; Owusu-Dabo, Ellis; Rakotozandrindrainy, Raphaël; Bassiahi Soura, Abdramane; Aseffa, Abraham; Gasmelseed, Nagla; Sooka, Arvinda; Keddy, Karen H; May, Jürgen; Aaby, Peter; Biggs, Holly M; Hertz, Julian T; Montgomery, Joel M; Cosmas, Leonard; Olack, Beatrice; Fields, Barry; Sarpong, Nimako; Razafindrabe, Tsiriniaina Jean Luco; Raminosoa, Tiana Mirana; Kabore, Leon Parfait; Sampo, Emmanuel; Teferi, Mekonnen; Yeshitela, Biruk; El Tayeb, Muna Ahmed; Krumkamp, Ralf; Dekker, Denise Myriam; Jaeger, Anna; Tall, Adama; Gassama, Amy; Niang, Aissatou; Bjerregaard-Andersen, Morten; Løfberg, Sandra Valborg; Deerin, Jessica Fung; Park, Jin Kyung; Konings, Frank; Carey, Megan E; Van Puyvelde, Sandra; Ali, Mohammad; Clemens, John.
Afiliação
  • Park SE; International Vaccine Institute, Seoul, Republic of Korea.
  • Pham DT; Graduate School of Public Health, Yonsei University, Seoul, Republic of Korea.
  • Pak GD; The Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
  • Panzner U; Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.
  • Maria Cruz Espinoza L; International Vaccine Institute, Seoul, Republic of Korea.
  • von Kalckreuth V; International Vaccine Institute, Seoul, Republic of Korea.
  • Im J; International Vaccine Institute, Seoul, Republic of Korea.
  • Mogeni OD; International Vaccine Institute, Seoul, Republic of Korea.
  • Schütt-Gerowitt H; International Vaccine Institute, Seoul, Republic of Korea.
  • Crump JA; International Vaccine Institute, Seoul, Republic of Korea.
  • Breiman RF; International Vaccine Institute, Seoul, Republic of Korea.
  • Adu-Sarkodie Y; Institute of Medical Microbiology, University of Cologne, Cologne, Germany.
  • Owusu-Dabo E; Centre for International Health, University of Otago, Dunedin, New Zealand.
  • Rakotozandrindrainy R; Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, USA.
  • Bassiahi Soura A; Duke Global Health Institute, Duke University, Durham, North Carolina, USA.
  • Aseffa A; Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
  • Gasmelseed N; Centers for Disease Control and Prevention, KEMRI Complex, Nairobi, Kenya.
  • Sooka A; Global Health Institute, Emory University, Atlanta, Georgia, USA.
  • Keddy KH; Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • May J; Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana.
  • Aaby P; Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Biggs HM; Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana.
  • Hertz JT; University of Antananarivo, Antananarivo, Madagascar.
  • Montgomery JM; Institut Supérieur des Sciences de la Population, University of Ouagadougou, Ouagadougou, Burkina Faso.
  • Cosmas L; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
  • Olack B; Faculty of Medicine, University of Gezira, Wad Medani, Sudan.
  • Fields B; Faculty of Science, University of Hafr Al Batin, Hafr Albatin, Saudi Arabia.
  • Sarpong N; National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Razafindrabe TJL; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Raminosoa TM; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Kabore LP; German Center for Infection Research, Braunschweig, Germany.
  • Sampo E; Bandim Health Project, Bissau, Guinea-Bissau.
  • Teferi M; Research Center for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, Copenhagen, Denmark.
  • Yeshitela B; Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, USA.
  • El Tayeb MA; Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
  • Krumkamp R; Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, USA.
  • Dekker DM; Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
  • Jaeger A; Centers for Disease Control and Prevention, KEMRI Complex, Nairobi, Kenya.
  • Tall A; Centers for Disease Control and Prevention, KEMRI Complex, Nairobi, Kenya.
  • Gassama A; Kenya Medical Research Institute, Nairobi, Kenya.
  • Niang A; Centers for Disease Control and Prevention, KEMRI Complex, Nairobi, Kenya.
  • Bjerregaard-Andersen M; Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Løfberg SV; German Center for Infection Research, Braunschweig, Germany.
  • Deerin JF; University of Antananarivo, Antananarivo, Madagascar.
  • Park JK; University of Antananarivo, Antananarivo, Madagascar.
  • Konings F; Schiphra Hospital, Ouagadougou, Burkina Faso.
  • Carey ME; Schiphra Hospital, Ouagadougou, Burkina Faso.
  • Van Puyvelde S; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
  • Ali M; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
  • Clemens J; Faculty of Medicine, University of Gezira, Wad Medani, Sudan.
BMJ Glob Health ; 6(8)2021 08.
Article em En | MEDLINE | ID: mdl-34341020
ABSTRACT

BACKGROUND:

Invasive non-typhoidal Salmonella (iNTS) is one of the leading causes of bacteraemia in sub-Saharan Africa. We aimed to provide a better understanding of the genetic characteristics and transmission patterns associated with multi-drug resistant (MDR) iNTS serovars across the continent.

METHODS:

A total of 166 iNTS isolates collected from a multi-centre surveillance in 10 African countries (2010-2014) and a fever study in Ghana (2007-2009) were genome sequenced to investigate the geographical distribution, antimicrobial genetic determinants and population structure of iNTS serotypes-genotypes. Phylogenetic analyses were conducted in the context of the existing genomic frameworks for various iNTS serovars. Population-based incidence of MDR-iNTS disease was estimated in each study site.

RESULTS:

Salmonella Typhimurium sequence-type (ST) 313 and Salmonella Enteritidis ST11 were predominant, and both exhibited high frequencies of MDR; Salmonella Dublin ST10 was identified in West Africa only. Mutations in the gyrA gene (fluoroquinolone resistance) were identified in S. Enteritidis and S. Typhimurium in Ghana; an ST313 isolate carrying blaCTX-M-15 was found in Kenya. International transmission of MDR ST313 (lineage II) and MDR ST11 (West African clade) was observed between Ghana and neighbouring West African countries. The incidence of MDR-iNTS disease exceeded 100/100 000 person-years-of-observation in children aged <5 years in several West African countries.

CONCLUSIONS:

We identified the circulation of multiple MDR iNTS serovar STs in the sampled sub-Saharan African countries. Investment in the development and deployment of iNTS vaccines coupled with intensified antimicrobial resistance surveillance are essential to limit the impact of these pathogens in Africa.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Salmonella typhimurium / Preparações Farmacêuticas Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Child / Humans País/Região como assunto: Africa Idioma: En Revista: BMJ Glob Health Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Salmonella typhimurium / Preparações Farmacêuticas Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Child / Humans País/Região como assunto: Africa Idioma: En Revista: BMJ Glob Health Ano de publicação: 2021 Tipo de documento: Article